By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following on last week's announcement of preliminary financial results, Clinical Data today reported flat fourth-quarter revenue growth and an increased net loss on higher R&D spending.

The Newton, Mass.-based firm reported a 26 percent increase in its full-year revenues compared to fiscal-year 2009 and sharp decrease in its net loss year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.